CN101217939A - 可注射组合物及制备这类组合物的方法 - Google Patents

可注射组合物及制备这类组合物的方法 Download PDF

Info

Publication number
CN101217939A
CN101217939A CNA2006800250937A CN200680025093A CN101217939A CN 101217939 A CN101217939 A CN 101217939A CN A2006800250937 A CNA2006800250937 A CN A2006800250937A CN 200680025093 A CN200680025093 A CN 200680025093A CN 101217939 A CN101217939 A CN 101217939A
Authority
CN
China
Prior art keywords
compositions
mixture
cox
solution
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800250937A
Other languages
English (en)
Chinese (zh)
Inventor
R·简
K·C·津达尔
S·辛格
S·博尔哈内
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panacea Biotec Ltd
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of CN101217939A publication Critical patent/CN101217939A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2006800250937A 2005-05-27 2006-05-25 可注射组合物及制备这类组合物的方法 Pending CN101217939A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1357DE2005 2005-05-27
IN1357/DEL/2005 2005-05-27

Publications (1)

Publication Number Publication Date
CN101217939A true CN101217939A (zh) 2008-07-09

Family

ID=36917368

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800250937A Pending CN101217939A (zh) 2005-05-27 2006-05-25 可注射组合物及制备这类组合物的方法

Country Status (15)

Country Link
EP (1) EP1895983A2 (xx)
JP (1) JP2008542260A (xx)
KR (1) KR20080016689A (xx)
CN (1) CN101217939A (xx)
AU (1) AU2006250765A1 (xx)
BR (1) BRPI0611170A2 (xx)
CA (1) CA2609242A1 (xx)
CR (1) CR9616A (xx)
EA (1) EA200702646A1 (xx)
MX (1) MX2007014862A (xx)
NO (1) NO20076468L (xx)
RS (1) RS20070461A (xx)
TN (1) TNSN07482A1 (xx)
WO (1) WO2006126214A2 (xx)
ZA (1) ZA200711068B (xx)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102335114A (zh) * 2010-07-23 2012-02-01 重庆医药工业研究院有限责任公司 一种稳定的布洛芬精氨酸注射剂及其制备方法
CN102370615A (zh) * 2010-08-19 2012-03-14 四川科伦药物研究有限公司 一种布洛芬注射制剂及其制备方法
CN102413687A (zh) * 2009-03-12 2012-04-11 坎伯兰医药品股份有限公司 静脉注射布洛芬的施用
CN103263385A (zh) * 2013-05-17 2013-08-28 江苏正大清江制药有限公司 一种塞来昔布长效纳米注射剂及其制备方法
CN103372216A (zh) * 2012-04-26 2013-10-30 北京京卫燕康药物研究所有限公司 一种含有塞来昔布的固体药物组合物
US9295639B2 (en) 2009-07-15 2016-03-29 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
CN107303266A (zh) * 2016-04-18 2017-10-31 重庆润泽医药有限公司 左旋奥拉西坦注射液及其制备方法
CN107303264A (zh) * 2016-04-18 2017-10-31 重庆润泽医药有限公司 无泡沫左旋奥拉西坦注射液及其制备方法
CN109498852A (zh) * 2018-12-29 2019-03-22 广州噢斯荣医药技术有限公司 治疗骨科疾病的生物降解材料及其应用
US11806400B2 (en) 2012-03-16 2023-11-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103181893A (zh) 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
MX2014004566A (es) 2011-10-18 2014-07-09 Raqualia Pharma Inc Composicion farmaceutica.
CN102512383A (zh) * 2011-12-25 2012-06-27 天津市嵩锐医药科技有限公司 供注射用的帕瑞昔布钠药物组合物
TWI646091B (zh) 2012-12-28 2019-01-01 日商衛斯克慧特股份有限公司 鹽類及晶形
US20140187635A1 (en) 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
SG11201704435PA (en) * 2014-12-20 2017-06-29 Troikaa Pharmaceuticals Ltd Injectable formulations of paracetamol
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
FR3077984B1 (fr) * 2018-02-16 2020-02-21 Vetoquinol Sa Composition multiusage de torasemide
CN111103381A (zh) * 2019-12-25 2020-05-05 南京希麦迪医药科技有限公司 一种液质联用测定人血浆中尼美舒利浓度的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
IN187306B (xx) * 1998-01-12 2002-03-23 Panacea Biotec Ltd
MY137736A (en) * 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition
AU2003249510A1 (en) * 2002-08-12 2004-02-25 Ranbaxy Laboratories Limited A parenteral dosage form of selective cox-2 inhibitors

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102413687A (zh) * 2009-03-12 2012-04-11 坎伯兰医药品股份有限公司 静脉注射布洛芬的施用
US9012508B2 (en) 2009-03-12 2015-04-21 Cumberland Pharmaceuticals Administration of intravenous ibuprofen
US9931311B2 (en) 2009-07-15 2018-04-03 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
US9649284B2 (en) 2009-07-15 2017-05-16 Cumberland Pharmaceuticals, Inc. Treating critically ill patients with intravenous ibuprofen
US9295639B2 (en) 2009-07-15 2016-03-29 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
CN102335114B (zh) * 2010-07-23 2015-07-15 重庆医药工业研究院有限责任公司 一种稳定的布洛芬精氨酸注射剂及其制备方法
CN102335114A (zh) * 2010-07-23 2012-02-01 重庆医药工业研究院有限责任公司 一种稳定的布洛芬精氨酸注射剂及其制备方法
CN102370615B (zh) * 2010-08-19 2013-09-04 四川科伦药物研究有限公司 一种布洛芬注射制剂及其制备方法
CN102370615A (zh) * 2010-08-19 2012-03-14 四川科伦药物研究有限公司 一种布洛芬注射制剂及其制备方法
US11806400B2 (en) 2012-03-16 2023-11-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN103372216B (zh) * 2012-04-26 2015-05-06 北京京卫燕康药物研究所有限公司 一种含有塞来昔布的固体药物组合物
CN103372216A (zh) * 2012-04-26 2013-10-30 北京京卫燕康药物研究所有限公司 一种含有塞来昔布的固体药物组合物
CN103263385A (zh) * 2013-05-17 2013-08-28 江苏正大清江制药有限公司 一种塞来昔布长效纳米注射剂及其制备方法
CN107303266A (zh) * 2016-04-18 2017-10-31 重庆润泽医药有限公司 左旋奥拉西坦注射液及其制备方法
CN107303264A (zh) * 2016-04-18 2017-10-31 重庆润泽医药有限公司 无泡沫左旋奥拉西坦注射液及其制备方法
CN107303266B (zh) * 2016-04-18 2020-09-08 重庆润泽医药有限公司 左旋奥拉西坦注射液及其制备方法
CN109498852A (zh) * 2018-12-29 2019-03-22 广州噢斯荣医药技术有限公司 治疗骨科疾病的生物降解材料及其应用
CN109498852B (zh) * 2018-12-29 2022-06-24 广州噢斯荣医药技术有限公司 治疗骨科疾病的生物降解材料及其应用

Also Published As

Publication number Publication date
EP1895983A2 (en) 2008-03-12
KR20080016689A (ko) 2008-02-21
TNSN07482A1 (fr) 2009-03-17
CA2609242A1 (en) 2006-11-30
RS20070461A (xx) 2008-11-28
BRPI0611170A2 (pt) 2010-08-17
ZA200711068B (en) 2009-03-25
MX2007014862A (es) 2008-02-21
WO2006126214A3 (en) 2007-06-07
AU2006250765A1 (en) 2006-11-30
WO2006126214A2 (en) 2006-11-30
CR9616A (es) 2008-10-30
JP2008542260A (ja) 2008-11-27
NO20076468L (no) 2008-02-27
EA200702646A1 (ru) 2008-06-30

Similar Documents

Publication Publication Date Title
CN101217939A (zh) 可注射组合物及制备这类组合物的方法
CN100366244C (zh) 含有抗真菌剂的局部用组合物
ES2263182T3 (es) Composicion adecuada para el tratamiento de laminitis equina.
TW442295B (en) Stable freeze-dried pharmaceutical composition
JP3925900B2 (ja) 水素化ヒマシ油を含有する持続性注射剤
KR20090090387A (ko) 음료수 시스템 내에 추가하기 위한 플로르페니콜의 비등성 제형
US20080027011A1 (en) Homogeneous paste and gel formulations
JP2023154054A (ja) 抗寄生生物性ポアオン組成物
US8859603B2 (en) Method for solubilizing metronidazole
US7879899B2 (en) Injectable veterinary composition for small animals
CA2673193C (en) Homogeneous paste and gel formulations
PT1646425E (pt) Composição parasiticida
JP2018021027A (ja) ロキソプロフェンを含有する医薬製剤
US20060014834A1 (en) Retinoid solutions and formulations made therefrom
US20130089575A1 (en) Pharmaceutical methods and topical compositions containing acitretin
CN102202651A (zh) 3-(2,2,2-三甲基肼)丙酸盐二水合物的外用制剂
RU2649809C2 (ru) Жидкая гомогенная фаза для трансдермальных фармацевтических композиций
CN117715623A (zh) 恩杂鲁胺的新型口服液组合物及其制备方法
TW200418516A (en) Droplet dispersed ointment
ES2316308B1 (es) Medicamento a base de metronidazol y acido azelaico para el tratamiento por via topica de la enfermedad rosacea de mejor asimilacion, y procedimiento de preparacion.
EP2145618A1 (en) Retinoid solutions and formulations made thereform
WO2004014431A1 (en) A parenteral dosage form of selective cox-2 inhibitors

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1119574

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20080709

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1119574

Country of ref document: HK